newsfilter
← Latest News
PR Newswire·

Lipocine Receives Updated Regulatory Guidance on LPCN 1154

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective...